SOMERSET, N.J., July 7 /PRNewswire-FirstCall/ -- The Franklin Group, a division of Ventiv Health, Inc. and a leader in the design and administration of patient assistance programs throughout the nation, announced today that Bill Shearer, Executive VP and COO, Ventiv Pharma Services, will participate in a panel discussion at the Ninth Annual 340B Coalition Conference taking place in Washington, DC July 11 - 13, 2005.
Mr. Shearer’s session - Patient Assistance Programs: Where Are We Now? - will provide an overview of the current state of PAPs and the efforts currently underway by the industry to simplify the application process. Mr. Shearer will be joined by a distinguished panel of speakers including David Chen, Director of the Section of Home, Ambulatory and Chronic Care Practitioners, American Society of Health-System Pharmacists and Kathryn Duke, Program Director, Medicine for People In Need.
The presentation will take place on Wednesday, July 13 at 8:00 a.m. at the J.W. Marriott in Washington, DC.
The 340B Coalition Conference is event is hosted by the 340B Coalition, a group of 17 national associations that represent the thousands of health care providers and programs participating in the Federal 340B drug discount program. This conference is unparalleled in providing timely information and relevant strategies for providers and industry representatives on how to provide high quality pharmaceutical care and handle various compliance issues. Featured will be key officials from Federal and State government who administer the 340B and Medicaid drug rebate programs and representatives from the Department of Justice, HHS OIG and State Attorney General Offices on various pricing investigations affecting 340B and Medicaid. The Office of Pharmacy Affairs (OPA) will also provide presentations.
About The Franklin Group
The Franklin Group, a division of Ventiv Health, is a pharmaceutical- specific consulting firm nationally recognized for its content and process expertise in the areas of regulatory compliance specific to sample accountability, the design and management of Patient Assistance Programs, and OIG consultative services to help you meet federal, state, and industry standards. For more information, visit http://www.franklinpharmaservices.com .
About Ventiv Health
Ventiv Health, Inc. is the leading provider of late-stage clinical, sales, marketing and compliance solutions to pharmaceutical and biotech companies. Ventiv is a multi- disciplinary company with a singular focus on providing excellence in customized solutions across the full spectrum of services combining both integrated and independent programs. Ventiv’s approximately 4,000 employees support over 75 client organizations, including the world’s Top 20 pharmaceuticals companies as well as emerging and specialty biotech leaders. For more information on Ventiv Health, visit http://www.ventiv.com .
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause Ventiv Health’s performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by Ventiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
Ventiv Health, Inc.
CONTACT: Investors-Corporate - John Emery, CFO of Ventiv Health, Inc.,+1-732-537-4804, investor@ventiv.com; or Media - Felicia Vonella,+1-212-867-1762, fvonella@lazarpartners.com, or Kellie Walsh,+1-646-871-8480, kwalsh@lazarpartners.com, both of Lazar Partners Ltd. forVentiv Health, Inc.
